Position history for TWO SIGMA ADVISERS, LP's holdings in ALNYLAM PHARMACEUTICALS INC
TWO SIGMA ADVISERS, LP holds 1.1M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $450.4M as of 2025-Q4. The position was increased (++26.9% shares). ALNY represents 0.9% of TWO SIGMA ADVISERS, LP's portfolio.
Current Value
$450.4M
Current Shares
1.1M
Total Value Change
+$387.5M
Total Shares Change
+873,860
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.1M |
+26.9% |
| $450.4M |
| 0.9% |
| $397.25 |
55 |
| 2025-Q3 | Increased | 892,500 | +235.4% | $407M | 0.8% | $447.49 | 71 |
| 2025-Q2 | Decreased | 266,100 | -3.5% | $86.8M | 0.2% | $322.83 | 0 |
| 2025-Q1 | Increased | 275,800 | +250.0% | $74.5M | 0.2% | $268.46 | 57 |
| 2024-Q4 | Decreased | 78,800 | -23.6% | $18.5M | 0.0% | $236.01 | 0 |
| 2024-Q3 | Decreased | 103,100 | -60.1% | $28.4M | 0.1% | $274.91 | 0 |
| 2024-Q2 | Increased | 258,700 | +36.5% | $62.9M | 0.1% | $243.00 | 46 |